Recombinant Super-Compound Interferon
- Generic Name
- Recombinant Super-Compound Interferon
- Drug Type
- Biotech
- Background
Recombinant super-compound interferon (rSIFN-co) is a recombinant version of interferon alpha with modified spatial configuration. This interferon has antiviral and antitumor activity.
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
Phase 2
Completed
- Conditions
- COVID-19SARS-CoV-2 Infection
- Interventions
- Drug: Placebo Nasal Spray
- First Posted Date
- 2022-08-03
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Sichuan Huiyang Life Science and Technology Corporation
- Target Recruit Count
- 188
- Registration Number
- NCT05485584
- Locations
- 🇵🇭
GreenCity Medical Center, San Fernando, Central Luzon, Philippines
🇵🇭Medical Center Manila, Manila, Philippines
Study of rSIFN-co for Patients With Advanced Solid Tumors
Phase 1
Terminated
- Conditions
- Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor
- Interventions
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Sichuan Huiyang Life Science and Technology Corporation
- Target Recruit Count
- 7
- Registration Number
- NCT02464007
- Locations
- 🇺🇸
HealthPartners Institute, Saint Paul, Minnesota, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Mayo Clinic, Phoenix, Arizona, United States
A Study of rSIFN-co in Subjects With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- MelanomaCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellColon CancerCarcinoma, Hepatocellular
- Interventions
- First Posted Date
- 2015-03-13
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- Sichuan Huiyang Life Science and Technology Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT02387307
- Locations
- 🇸🇬
National Cancer Centre Singapore, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath